NAMS
Price
$36.53
Change
-$1.13 (-3.00%)
Updated
Oct 21, 11:40 AM (EDT)
Capitalization
4.24B
27 days until earnings call
Intraday Buy/Sell Signals
OSTX
Price
$1.76
Change
-$0.07 (-3.83%)
Updated
Oct 21, 11:46 AM (EDT)
Capitalization
61.36M
24 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

NAMS vs OSTX

Header iconNAMS vs OSTX Comparison
Open Charts NAMS vs OSTXBanner chart's image
NewAmsterdam Pharma
Price$36.53
Change-$1.13 (-3.00%)
Volume$800
Capitalization4.24B
OS Therapies
Price$1.76
Change-$0.07 (-3.83%)
Volume$590
Capitalization61.36M
NAMS vs OSTX Comparison Chart in %
NAMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OSTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NAMS vs. OSTX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAMS is a Hold and OSTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 21, 2025
Stock price -- (NAMS: $37.66 vs. OSTX: $1.83)
Brand notoriety: NAMS and OSTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAMS: 147% vs. OSTX: 50%
Market capitalization -- NAMS: $4.24B vs. OSTX: $61.36M
NAMS [@Biotechnology] is valued at $4.24B. OSTX’s [@Biotechnology] market capitalization is $61.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAMS’s FA Score shows that 1 FA rating(s) are green whileOSTX’s FA Score has 0 green FA rating(s).

  • NAMS’s FA Score: 1 green, 4 red.
  • OSTX’s FA Score: 0 green, 5 red.
According to our system of comparison, NAMS is a better buy in the long-term than OSTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAMS’s TA Score shows that 4 TA indicator(s) are bullish while OSTX’s TA Score has 4 bullish TA indicator(s).

  • NAMS’s TA Score: 4 bullish, 4 bearish.
  • OSTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, NAMS is a better buy in the short-term than OSTX.

Price Growth

NAMS (@Biotechnology) experienced а +1.37% price change this week, while OSTX (@Biotechnology) price change was -6.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was +22.13%, and the average quarterly price growth was +71.28%.

Reported Earning Dates

NAMS is expected to report earnings on Nov 17, 2025.

OSTX is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NAMS($4.24B) has a higher market cap than OSTX($61.4M). NAMS YTD gains are higher at: 46.537 vs. OSTX (-57.243). OSTX has higher annual earnings (EBITDA): -13.72M vs. NAMS (-237.93M). NAMS has more cash in the bank: 739M vs. OSTX (2.8M). NAMS has less debt than OSTX: NAMS (328K) vs OSTX (16.7M). NAMS has higher revenues than OSTX: NAMS (64M) vs OSTX (0).
NAMSOSTXNAMS / OSTX
Capitalization4.24B61.4M6,909%
EBITDA-237.93M-13.72M1,734%
Gain YTD46.537-57.243-81%
P/E RatioN/AN/A-
Revenue64M0-
Total Cash739M2.8M26,374%
Total Debt328K16.7M2%
TECHNICAL ANALYSIS
Technical Analysis
NAMSOSTX
RSI
ODDS (%)
Bearish Trend 5 days ago
63%
Bullish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
51%
Bullish Trend 5 days ago
90%
Momentum
ODDS (%)
Bullish Trend 5 days ago
48%
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
Bullish Trend 5 days ago
56%
N/A
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
55%
Bearish Trend 5 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
59%
Bearish Trend 5 days ago
85%
Advances
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 16 days ago
88%
Declines
ODDS (%)
Bearish Trend 5 days ago
69%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
67%
Bullish Trend 5 days ago
90%
Aroon
ODDS (%)
Bullish Trend 5 days ago
75%
Bearish Trend 5 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
NAMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OSTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BSMAX18.450.27
+1.49%
iShares Russell Small/Mid-Cap Idx Inv A
SBASX13.020.19
+1.48%
Segall Bryant &Hamill Small Cap Cre Ins
RNGCX73.030.96
+1.33%
American Funds New Economy R3
AALRX29.270.30
+1.04%
American Beacon Large Cap Value R6
FLXSX17.68N/A
N/A
Fidelity Flex Small Cap Index

NAMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAMS has been loosely correlated with CRDF. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if NAMS jumps, then CRDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAMS
1D Price
Change %
NAMS100%
+3.46%
CRDF - NAMS
41%
Loosely correlated
+4.11%
BEAM - NAMS
40%
Loosely correlated
+17.86%
AURA - NAMS
37%
Loosely correlated
+6.88%
QURE - NAMS
37%
Loosely correlated
+10.21%
IDYA - NAMS
37%
Loosely correlated
+4.27%
More

OSTX and

Correlation & Price change

A.I.dvisor tells us that OSTX and PVLA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OSTX and PVLA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OSTX
1D Price
Change %
OSTX100%
-1.08%
PVLA - OSTX
30%
Poorly correlated
+6.18%
XNCR - OSTX
23%
Poorly correlated
+2.03%
NAMS - OSTX
23%
Poorly correlated
+3.46%
ACLX - OSTX
23%
Poorly correlated
-0.25%
ADMA - OSTX
22%
Poorly correlated
+2.30%
More